• Profile
Close

Short stature is progressive in patients with heterozygous NPR2 mutations

Journal of Clinical Endocrinology and Metabolism Aug 03, 2020

Hanley PC, Kanwar HS, Martineau C, et al. - Since biallelic loss-of-function mutations in NPR2 result in acromesomelic dysplasia Maroteaux type (AMDM; OMIM 602875), whereas heterozygous mutations may account for 2-6% of idiopathic short stature (ISS), researchers sought to explain the physical proportions and growth characteristics of an extended family with novel NPR2 mutations including members with AMDM, ISS, or normal stature. They conducted whole exome sequencing in two healthy parents and two children with AMDM. Both mutant atrial natriuretic peptide receptor B (ANPRB) proteins were normally expressed in HEK293T cells and showed dominant negative impacts on wild type ANPRB catalytic activity. Biallelic NPR2 mutations cause severe skeletal dysplasia (ADMD), while heterozygous mutations result in a subtler phenotype characterized by progressive short stature, which is characterized by increasing height loss potential with age.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay